Figure 4
Survival comparison between patients with CML with 3q26.2 abnormalities as the sole ACA and patients with CML with trisomy 8 as the sole ACA.
Survival comparison between patients with CML with 3q26.2 abnormalities as the sole ACA and patients with CML with trisomy 8 as the sole ACA.
